Pharmacovigilance is Not Just About Compliance

Dr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to report adverse drug events (ADEs) and how understanding the risk-benefit profile of your product can maximise benefit and minimising risk, by making sure the right drug, goes to the right patient, at the right time.